$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What is the effect of crizotinib?
2025-10-19 11:44:20
Check Details
What conditions need to be met before the anti-cancer drug entrectinib can be used?
2025-10-19 11:44:20
Check Details
Can gefitinib be used as first-line treatment for EGFR mutation-positive lung cancer?
2025-10-19 11:44:20
Check Details
Will the price of crizotinib drop in 2021
2025-10-19 11:44:20
Check Details
Is the new drug entrectinib a broad-spectrum anticancer drug?
2025-10-19 11:44:20
Check Details
Crizotinib medical insurance price in 2021
2025-10-19 11:44:20
Check Details
What diseases does Crizotinib Capsule treat? How much does it cost?
2025-10-19 11:44:20
Check Details
Price of crizotinib capsules after being covered by medical insurance
2025-10-19 11:44:20
Check Details
What drugs can be used to treat late-stage lung cancer? Can gefitinib be used?
2025-10-19 11:44:20
Check Details
What kind of medicine is Crizotinib (Xalkori) capsules
2025-10-19 11:44:20
Check Details
How much will a box of the targeted drug gefitinib cost after it enters medical insurance in 2021?
2025-10-19 11:44:20
Check Details
How long does it take for tumors to disappear after taking crizotinib
2025-10-19 11:44:20
Check Details
1
2
...
3895
3896
3897
3898
3899
3900
3901
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Cemiplimab (Libtayo) Drug Information
5
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
6
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
7
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide